Audio Adrenaline frontman Mark Stuart is considering recording new music with the help of artificial intelligence (AI), a possibility that could allow the Christian rock singer to return to the ...
Worship leaders have built new AI tools to help create setlists and score songs on qualities like scriptural grounding and clarity.
Sitting through an 8-year-old's shaky rendition of Christian Petzold's "Minuet in G" may be music to a proud parent's ear. To ...
Schlager-Ikone Wolfgang Petry begeht seinen 75. Geburtstag mit einem besonderen Geschenk an sich selbst. Dabei hat er auch verraten, wie er sich im Alter fit hält. Schlagerstar Wolfgang Petry, dessen ...
In einem richtungsweisenden Urteil hat das Landgericht München I der Klage der Verwertungsgesellschaft GEMA gegen den KI-Musikdienst Suno überwiegend stattgegeben. Das Gericht stellte unter dem ...
Hosted on MSN
BioNTech threw in the towel on its colorectal cancer vaccine trial. Should investors be worried?
BioNTech terminated a Phase 2 study of autogene cevumeran in treating colorectal cancer. The setback raises questions about the mRNA vaccine's prospects in treating pancreatic cancer. However, it's ...
Marantz, Cambridge Audio, Bang & Olufsen and NAD are just a few of the hi-fi brands to release new-age CD players over the past several months. See more of our coverage in your search results There’s ...
Enzo Maresca has introduced music to Manchester City training sessions Miguel Riopa/AFP via Getty Images It might have seemed more like a soundtrack suited to a nightclub than a top-level football ...
Die Annahme, sportliche Belastung über den Takt klassischer Musik gezielt zu steuern, stößt in der Trainingslehre regelmäßig auf Interesse. Im Zentrum der Diskussion steht dabei die These, dass ein ...
To understand the magnitude of this recent development, let's rewind the clock a bit. Moderna has been a pioneer in mRNA technology, and the company demonstrated the potential of its approach by ...
Autogene cevumeran, an mRNA-based personalized cancer immunotherapy, was originally developed by BioNTech. In September 2016, Roche, through its subsidiary Genentech, paid $310 million upfront and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results